Lam Research Corporation (NASDAQ: LRCX) extended its remarkable 2025 rally on Wednesday, with the stock trading around $155–$156 in late dealings, up roughly 2.7% on the day and more than 100% year-to-date on the back of soaring AI-related chip demand.
At the same time, a flurry of fresh research calls, options activity, and institutional filings is reshaping the risk–reward picture for investors following the semiconductor equipment leader.
Key Takeaways for LRCX on November 26, 2025
- Price action: LRCX trades near $155.97, up about 2.66% from yesterday’s close of $151.93, with an intraday range of $152.50–$156.98 and volume above 5.2 million shares.
- Valuation: Lam’s market cap is about $162 billion, with a P/E near 28x, reflecting premium pricing for AI-driven growth.
- 2025 performance: LRCX is among the top S&P 500 performers in 2025, with YTD gains of ~103–109%, depending on the source and cut‑off date.
- Analyst moves today:Zacks Research cut its rating from “Strong Buy” to “Hold,” but Street consensus remains a “Moderate Buy” with an average 12‑month target of about $152.17 and several firms lifting targets toward $170–$175. MarketBeat+1
- Options:New January 2026 options contracts listed today on Nasdaq, including highlighted put and covered call ideas around the $143 and $157.50 strikes.
- Institutional flows: Multiple 13F updates show large funds both adding and trimming positions, alongside a drop in total institutional shares outstanding of ~22% over the last quarter.
- Technical picture: LRCX is being flagged as a “high‑growth momentum stock” and remains in a firm uptrend, though some short‑term models see an attractive downside risk–reward setup for hedged strategies. ChartMill+1
Lam Research Stock Price Today: LRCX Extends Its 2025 Breakout
As of the latest quote on November 26, 2025, Lam Research stock trades at approximately:
- Last price:$155.97
- Change:+$4.04 (+2.66%) vs. prior close of $151.93
- Intraday low / high:$152.50 – $156.98
- Open:$152.98
- Volume: ~5.3 million shares
- Market cap: ~$162.4 billion
- Trailing P/E: ~27.95x
Over the last twelve months, LRCX has traded between a low of about $56.32 and a high near $167.15, underscoring just how dramatic 2025’s re‑rating has been.
Separate performance trackers show Lam sitting in the top tier of S&P 500 winners, with one Thanksgiving performance overview placing the stock at #8 for 2025 with a +103.3% gain, while Zacks pegs the rally around +109% YTD.
For investors, today’s move keeps LRCX within striking distance of its 52‑week high and well above its 50‑ and 200‑day moving averages, reinforcing the sense that Lam remains a core AI‑hardware winner in this cycle.
Analyst Actions: Zacks Downgrade vs. Broad Street Optimism
The most notable research headline today is a rating cut from Zacks Research, which downgraded Lam Research from “Strong Buy” to “Hold.” MarketBeat
According to MarketBeat’s summary of the move:
- Zacks’ downgrade comes after a huge run‑up in the stock and may reflect valuation caution rather than a negative view of fundamentals.
- Despite the cut, 26 analysts rate LRCX a “Buy” and 10 a “Hold,” giving the stock a consensus rating of “Moderate Buy.” MarketBeat+1
- The average 12‑month price target is about $152.17, modestly below the current share price, implying the Street as a whole sees limited upside from here without further estimate revisions.
Importantly, several major firms have recently raised their targets:
- Evercore ISI: target lifted from $115 to $170, rating “Outperform.” MarketBeat
- B. Riley: target moved from $160 to $175, rating “Buy.” MarketBeat
- Bernstein: target increased from $170 to $175, “Outperform.” MarketBeat
- UBS: reiterated a “Buy” with a $175 target, reaffirmed in a note summarized by Fintel today. Fintel
In short, one near‑term downgrade hasn’t shifted the broader bullish consensus, but it does highlight that valuation is getting tighter relative to published targets.
Options Update: New January 2026 Contracts for LRCX
On the derivatives side, Nasdaq reported that new January 2026 options are now available for Lam Research, expanding the toolkit for income and hedging strategies.
The piece highlights:
- A $143 strike put in the new January 2026 series, with pricing that effectively offers a discounted entry vs. today’s stock price for investors willing to take assignment.
- A $157.50 covered call idea for shareholders, with potential to boost returns if LRCX trades sideways or modestly higher into 2026.
The article frames these as examples of how traders might generate yield or define risk around a volatile, high‑growth name like Lam, emphasizing that options strategies need to be aligned with risk tolerance and time horizon.
Institutional Flows: Big Funds Shuffle Their LRCX Exposure
Today brought a wave of 13F‑related headlines summarizing how large investors repositioned around LRCX in the latest quarter:
- MIG Capital LLC
- Increased its Lam position by ~269.8%, to 31,417 shares worth roughly $3.06 million.
- Russell Investments Group Ltd.
- Sold 488,158 shares, reducing its stake by 22.2% to 1,706,514 shares.
- Hel Ved Capital Management Ltd
- Cut its Lam holdings by 78.7%, selling 105,250 shares and ending the quarter with 28,450 shares (~$2.77 million).
- Himension Capital Singapore PTE. LTD.
- Trimmed its position by 20.3%, selling 21,880 shares and holding 86,051 shares (~$8.38 million), about 0.7% of its portfolio.
- Jaffetilchin Investment Partners LLC
- Opened a new position of 3,732 shares worth roughly $363,000, adding one more institutional buyer to the register.
A separate Fintel update provides a broader context:
- Around 1,156 funds and institutions currently report positions in Lam Research.
- The average portfolio weight dedicated to LRCX has risen ~7.2%, but total institutional shares have fallen ~22% over the past three months, implying profit‑taking by some holders even as others lean in more heavily.
The same MarketBeat piece that covered today’s Zacks downgrade also notes that insiders sold roughly 102,608 shares last quarter, worth about $14.9 million, including notable sales by CFO Douglas Bettinger and executive Ava Harter.
Takeaway: institutional and insider activity today paints a nuanced picture — no exodus, but clear evidence of de‑risking and profit‑locking after a huge run, even as select managers and index funds continue to accumulate exposure.
Momentum and Technical View: High‑Growth Trend, but Signals Turning More Nuanced
Screeners and trading models published today are largely aligned on one theme: Lam Research is a powerful momentum stock — but not without risk.
ChartMill: High‑Growth Momentum Candidate
A fresh note from ChartMill labels LRCX as a “high‑growth momentum stock” based on a combination of:
- Compliance with Mark Minervini’s trend template, which focuses on names in firm uptrends with strong relative strength.
- Solid earnings and revenue growth metrics that help justify the price action.
The tool’s snapshot at 11:21 a.m. ET shows:
- Price: about $155.75
- Daily gain:+2.51%
ChartMill concludes that Lam is an attractive candidate for further analysis for investors running momentum or growth screens, while cautioning that the analysis is for educational purposes and not direct advice.
StockTradersDaily: AI‑Driven Signals and Risk–Reward Setups
StockTradersDaily published an AI‑driven note titled “Behavioral Patterns of LRCX and Institutional Flows” early this morning, offering a more tactical view: Stock Traders Daily
Key points from their model:
- Near‑term (1–5 days): Strong bullish signal, with support around $144.28 and resistance near $153.33.
- Mid‑term (5–20 days): Weak signal, suggesting a period of consolidation or vulnerability after the recent surge.
- Long‑term (20+ days): Strong uptrend, with key levels around $135.06 (support) and $156.31 (resistance).
- They highlight what they describe as an “exceptional” 47.2:1 risk‑reward short setup targeting about 13.6% downside vs. 0.3% risk, reflecting how stretched the stock looks to some tactical traders at current levels. Stock Traders Daily
This framing illustrates the current tension between trend‑followers and contrarians: the structural story remains strong, but short‑term models see pockets of overextension.
Fundamental Backdrop: AI Spending, Earnings Beat, and Oregon Expansion
Despite the frothy chart, Lam’s recent fundamentals have been robust.
Latest Quarterly Results
In its September 2025 quarter (reported October 22), Lam delivered:
- Revenue:$5.32 billion, up from $5.17 billion sequentially.
- Non‑GAAP EPS:$1.26, beating consensus estimates of about $1.22.
- Non‑GAAP gross margin: ~50.6%, with operating margin around 35.0%.
- Net income: about $1.60 billion on a non‑GAAP basis.
MarketBeat’s aggregation of analyst commentary notes that revenue was up roughly 27.7% year‑over‑year, with EPS up strongly as well, leading to a return on equity above 60% and net margins near 30% — elite numbers even in the semiconductor space.
Lam also provided Q2 FY2026 EPS guidance in the $1.05–$1.25 range and announced a quarterly dividend of $0.26 per share, with the most recent dividend declaration coming on November 6, 2025 (ex‑dividend date early December).
AI‑Era Capacity Expansion in Oregon
On the strategic front, Lam is deepening its presence in the “Silicon Forest” near Portland:
- A recent press release details the expansion of its Tualatin, Oregon campus, with state and local officials joining company leadership to mark the investment.
- The expansion is framed as a move to support advanced AI‑era semiconductor manufacturing, strengthening Lam’s ability to deliver etch, deposition, and other critical tools for cutting‑edge chips.
Third‑party coverage earlier this week highlighted that this Oregon expansion, alongside strong earnings, helped drive a 5%+ surge in LRCX on November 24, as investors rewarded both near‑term execution and long‑term capacity positioning.
AI Capex Tailwinds
Multiple research shops and media outlets have emphasized that Lam’s 2025 run is anchored in:
- Record wafer fab equipment (WFE) spending, especially for advanced logic and AI‑focused memory.
- Its strong competitive position in etch and deposition tools critical for advanced nodes and new transistor architectures (e.g., gate‑all‑around).
These dynamics help explain why LRCX has been repeatedly cited as a top AI hardware beneficiary and one of the best‑performing S&P 500 stocks of the year.
Valuation Snapshot: How Stretched Is LRCX After a 100%+ Run?
Putting the pieces together:
- Price: ~$156
- Consensus target: ~$152.17 (slight downside vs. current level).
- Trailing P/E: ~28x.
- Revenue growth (latest fiscal year): ~24% YoY to about $18.44 billion.
- Earnings growth (latest fiscal year): ~40% YoY to $5.36 billion.
Relative to peers like Applied Materials and ASML, Lam is trading at a premium consistent with its recent growth spurt and AI leverage, but not wildly out of line with other high‑quality semiconductor equipment names. Recent sector commentary comparing Applied Materials’ margin expansion to peers notes that both Lam and ASML have seen improving gross and operating margins as AI demand ramps.
However, today’s Zacks downgrade, multiple institutional trims, and AI trading models highlighting skewed risk–reward suggest that, at least in the near term, expectations are very high and the margin for error is shrinking.
Is Lam Research Stock a Buy After Today’s Move?
Whether LRCX is attractive at current levels depends heavily on time horizon and risk tolerance:
Arguments the Bulls Will Lean On
- AI super‑cycle exposure: Lam is deeply tied to AI data center build‑outs, advanced logic, and memory, where capex visibility remains strong.
- Outstanding fundamentals: High‑20s to 30%+ margins, double‑digit revenue growth, and outsized returns on equity and capital.
- Long‑term uptrend: Multiple technical frameworks still point to a structurally bullish trend, with pullbacks so far being bought aggressively.
- Ongoing capital returns: A growing dividend plus the potential for continued buybacks support total‑return potential.
Risks and Reasons for Caution
- Valuation near or above targets: With the stock already above the consensus price target, further upside may require another leg of earnings upgrades or AI capex surprises.
- Cyclical exposure: Semiconductor equipment remains a highly cyclical industry; AI and memory booms can cool quickly if macro or end‑demand wobbles.
- Institutional and insider selling: The steady drumbeat of 13F filings showing substantial position cuts and notable insider sales hints that sophisticated holders are locking in profits after the 2025 spike.
- Short‑term technical risk: AI‑driven models flag attractive short hedges around current levels, pointing to elevated downside risk if sentiment shifts.
Bottom Line
On November 26, 2025, Lam Research stock continues to trade like a flagship AI beneficiary:
- Price action and technicals remain impressively strong.
- Earnings and margins are supportive of a premium valuation.
- Fresh news today — from Zacks’ downgrade to new January 2026 options, plus heavy institutional reshuffling — suggests the bull story is intact but no longer under the radar.
For long‑term investors who believe the AI hardware spending cycle has years left to run, Lam Research may still warrant a place on the watchlist or in a diversified portfolio — provided they are comfortable with heightened volatility and cyclical risk.
For short‑term traders, today’s blend of momentum, stretched valuations, and mixed institutional signals makes LRCX a name where position sizing, stop‑loss discipline, and time horizon matter more than ever.
